GlassScriptPhysician profile
Ben H Han
NPI 1245229350
$1,066.04
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.12 · 2020: $39.90 · 2021: $468 · 2022: $242 · 2023: $225 · 2024: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $156.02 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $133.35 | 2023 | Libtayo |
| Janssen Biotech, INC. | $87.31 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $80.27 | 2021-2023 | |
| Seagen INC. | $67.33 | 2021-2023 | Adcetris |
| Genzyme Corporation | $66.32 | 2021 | |
| Mirati Therapeutics, INC. | $46.94 | 2023 | Krazati |
| Tactile Systems Technology INC | $46.40 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Medtronic, INC. | $44.54 | 2021-2022 | |
| Endomagnetics LTD | $32.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.74 | 2019 | |
| Celgene Corporation | $26.02 | 2022 | |
| Adaptive Biotechnologies Corporation | $22.55 | 2022 | |
| Pharmacosmos Therapeutics INC. | $22.22 | 2022 | |
| Lilly USA, LLC | $22.19 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortovia Therapeutics, INC. | $22.09 | 2019 | |
| Morphosys, US INC. | $21.64 | 2021 | |
| Novocure INC. | $21.01 | 2022 | |
| Incyte Corporation | $19.87 | 2021 | |
| Amgen INC. | $19.80 | 2022 | |
| Advanced Accelerator Applications | $18.50 | 2020 | |
| Jazz Pharmaceuticals INC. | $16.72 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.29 | 2019 | |
| Foundation Medicine, INC. | $14.13 | 2021 | |
| Merck Sharp & Dohme LLC | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.